【レポートの概要(一部)】
1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
2.11 Glossary of Terms Related to Drug Discovery Outsourcing
3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2016-2026
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2015
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2026
3.5 The Changing Market Shares by Sector, 2015-2026
3.6 The Global Chemistry Services Outsourcing Market, 2015
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2026
3.7 The Global Biology Services Outsourcing Market, 2015
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2026
3.8 The Global Lead Optimisation Market, 2015
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2015-2026
3.9 The Global Lead Identification and Screening Outsourcing Market, 2015
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2026
4. The Leading National Markets in the Drug Discovery Outsourcing Market 2015-2026
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2015
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2026
4.7.2 CAGRs by EU5 Region, 2015-2026
4.7.3 The EU5 Changing Market Shares by Country 2015-2026
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
5. Leading Companies in the Drug Discovery Outsourcing Market
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Historical Sales and Recent Financial Performance, 2011-2014
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.4.4 AMRI (DDS) Sales Forecast, 2015-2026
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for VeronaCentre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.6 Charles River Laboratories
5.6.1 Sales and Historical Financial Performance, 2011-2014
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2013-2014
5.6.4 Charles River Laboratories Sales Forecast, 2015-2026
5.7 Covance (Acquired by Laboratory Corporation of America)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with Bio Pontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with EliLilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2014
5.8.2 Cyprotex: Revenue by Region, 2015
5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2026
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKεInhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Historical Revenue and Financial Analysis, 2010-2014
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharmaceuticals
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCBPharma
5.10.5 Evotec Sales Forecast, 2015-2026
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 Quintiles
5.13.1 Quintiles: Historical Revenue and Financial Performance, 2009-2014
5.13.2 Development Deal With Merck
5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
5.13.4 Quintiles: SheddingJobs
5.13.5 Quintiles Sales Forecast, 2015-2026
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.2 Initiative with the University of Edinburgh
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest Bio Research
5.17 WuXi Apptec
5.17.1 WuXi AppTec: Service Offerings
5.17.2 Acquisition of Next CODE Health
5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
5.17.4 WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026
6. Quantitative Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2016-2026
6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.3 Strengths
6.3.1 Cost Reduction: A Central Driver for Outsourcing
6.3.2 Accelerating the Discovery of Drug Candidates
6.3.3 Growth of Virtual Pharmaceutical Companies
6.3.4 Reduction in R&D capacity Within Big Pharma
6.4 Weaknesses
6.4.1 Slowing Trajectory of Growth for R&D Spending
6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
6.5 Opportunities
6.5.1 The Available Scope for the Expansion of CROs
6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
6.5.3 Increasing Development of Biologics and Biosimilars
6.6 Threats
6.6.1 A Competitive Market is Increasing Consolidation
6.6.2 Threat of Private Public Alliances
6.6.3 Intellectual Property Leaks
6.6.4 Challenges of Technology Transfer
6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market
6.7.1 Threat of New Entrants: Medium
6.7.2 Power of Suppliers: Medium
6.7.3 Threat of Substitutes: Medium
6.7.4 Power of Buyers: High
6.7.5 Rivalry Among Competitors: High
7. Expert Opinions
7.1 Interview with Dr. Mario Polywka, Chief Operating Officer, Evotec
7.1.1 Bridging the Gap Between Academia and BigPharma
7.1.2 Evotec: Specialises in Certain Disease Therapies
7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
7.1.4 Strategies for Drug Discovery Outsourcing Expansion
7.1.5 Building Trust in Collaborations
7.1.6 Evotec: Proven Track Record of Success
7.2 Dr. John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
7.2.1 Growth in the Full Spectrum of Outsourcing Services
7.2.2 Natural Products: Increasing Source of Drug Discovery
7.2.3 Strong Pool of Early Drug Candidates
7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
7.2.5 Selcia: Regional Base of Clients
7.2.6 Drug Discovery and Emerging Technologies
7.2.7 Med Chem Plus Projects
7.2.8 Varied Customer Base
7.2.9 CROs: Improving Drug Discovery Productivity Levels?
7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
7.3.1 End-to-End Drug Discovery Integration Growth
7.3.2 Whole Project Externalisation
7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services
7.3.4 Aptuit INDiGO® Program
7.3.5 Aptuit Implementation Drug Discovery Acquisitions
7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
7.3.7 Several Partners in the Drug Discovery Model
8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks
【レポート販売概要】
■ タイトル:創薬アウトソーシングの世界市場予測2016-2026■ 英文:Drug Discovery Outsourcing Market Forecast 2016-2026
■ 発行日:2016年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN61119
■ 調査対象地域:グローバル
- 世界の送配電(Transmission and Distribution)装備市場:Global T&D Equipment Market 2014-2018TechNavio's analysts forecast the Global T&D Equipment market to grow at a CAGR of 9.45 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in demand of T&D equipment from developing nations. The Global T&D Equipment market has also been witnessing the increasing outsourcing of manufacturing activities to the developing countries. However, t …
- 界面活性剤の世界市場分析:製品別(カチオン性、非イオン性、アニオン性、両性)、用途別(ホームケア、パーソナルケア、産業および施設洗浄剤、食品加工、油田化学、農薬、繊維、乳化重合、塗料および塗装、建設)、セグメント予測、– 2022The global surfactants market is expected to reach USD 46.20 billion by 2022, according to a new report by Grand View Research, Inc. Growth of personal care industry particularly in Asia Pacific, Latin America and Middle East is expected to remain a key driving factor for the global market. Growing demand for oilfield chemicals owing increasing drilling activities for unconventional energy in the …
- グローバル菓子類市場におけるM&A動向(2014年3月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global confectionery market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global confectionery market throughout the month. Additionally, the report provides an overview of all th …
- イギリスの手術室用装置市場見通し(~2021)United Kingdom Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Operating Room Equipment Market Outlook to 2021", provides key market data on the United Kingdom Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables …
- 腫瘍アブレーションの世界市場:高周波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IRE、超音波The global tumor ablation market is poised to grow at a CAGR of 11.5% during the forecast period (2015-2020), and is expected to reach a value of ~515.2 million by 2020. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. Growth in the tumor …
- コネクテッド農業ソリューションの世界市場:農業取引、入札、交換The evolution of agricultural technologies has witnessed a major acceptance in the agricultural industry in the recent years as they have resulted in improved revenue margins and levels of income of agricultural households in rural areas. This has encouraged organizations to provide better agri-mobile based solutions for farmers in developing regions. With the increase in the levels of corruption …
- ジェスチャー認識およびタッチレスセンシングの世界市場予測(~2022):衛生設備機器、タッチレス生体認証According to the MarketsandMarkets forecast, the gesture recognition market is expected to be worth USD 18.98 Billion by 2022, growing at a CAGR of 29.63% between 2017 and 2022. The touchless sensing market is expected to be worth USD 15.27 Billion by 2022, growing at a CAGR of 17.44% between 2017 and 2022. The major drivers for the market include the surging application of gesture control feature …
- Richard Wolf GmbH:市場シェア分析Richard Wolf GmbH Market Share Analysis Summary GlobalData’s new report, “Richard Wolf GmbH Market Share Analysis” provides in-depth information on Richard Wolf GmbH’s market position in the different medical equipment markets it operates in. The report provides Richard Wolf GmbH market share information in two key market categories – Rigid Endoscopes and Flexible Endoscopes. The report also provi …
- ハイパワーLEDの世界市場予測(~2024年)“High power LED market projected to grow at 4.5% CAGR during 2019–2024” The high power LED market is expected to grow from USD 4.5 billion in 2019 to USD 5.6 billion by 2024, at a CAGR of 4.5% during the forecast period. The long life & continuous usage, small size, less power consumption & low voltage, and increasing high brightness application are the major factors fueling the growth of the over …
- ボトル入り湧水の世界市場2017-2021About Bottled Spring WaterThe spring water originates from an underground source from which water naturally rises to the surface. Spring water is found to be a natural source of minerals and is considered to be free of most contaminants typically found in the drinking water. Also, spring water helps to maintain the acidity level in the body as spring water is slightly alkaline in nature. The sprin …
- 窒素発生器の世界市場:種類別(PSA窒素発生器、膜窒素発生器、低温窒素発生器)、最終用途産業別(食品および飲料、輸送、医療および医薬品、電気および電子機器、化学薬品)The global nitrogen generators market was valued at $11,776.1 million in 2018, and is projected to reach $17,435.5 million in 2026, growing at a CAGR of 4.9%. Nitrogen generator is a type of industrial on-site gas generation systems. This system serves as an ideal method to supply nitrogen across many manufacturing industries such as metal, semiconductor, chemicals, and others. The factors that dr …
- スマートグリッドソリューションの世界市場:先端メータリングインフラ(AMI)、スマートグリッド配電、スマートグリッド通信、グリッド資産管理、地理情報システム、請求・顧客情報システムMarketsandMarkets forecasts the smart grid market size to grow from USD 19.8 Million in 2016 to USD 65.4 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 27.0%. Mandatory regulations and policies, increasing concern for reducing carbon footprints, need for replacing aging infrastructure, and need for centralized gird distribution management and control are some of the key factors drivin …
- 全身性エリテマトーデス及びループス腎炎:世界市場(医薬品市場予測及び分析~2022)PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 Summary The lupus therapeutics market is dominated by generics and GlaxoSmithKline’s Benlysta is the only drug that has gained marketing approval for SLE in more than 50 years. Following Benlysta’s launch, patients’ uptake has remained low, but due to its associated high price-tag Benly …
- たばこ製造・販売企業分析:North Korean General Tobacco Corporation (NKGTC)Synopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: North Korean General Tobacco Corporation (NKGTC), including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portf …
- 世界のLAS(直鎖型アルキルベンゼンスルホン酸塩)市場2015The Global Linear Alkylbenzene Sulfonate (LAS) Industry Report 2015 is a professional and in-depth study on the current state of the Linear Alkylbenzene Sulfonate (LAS) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Linear Alkylbenzene Sulfonate (LAS) market analysis is provided for the internatio …